Cargando…
Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient
INTRODUCTION: Over the past year, 3 agents have been approved for the treatment of melanoma by the Food and Drug Administration. These include pegylated interferon α-2b for stage III melanoma, vemurafenib for unresectable or metastatic melanoma with BRAF V600E mutation, and ipilimumab for unresectab...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725017/ https://www.ncbi.nlm.nih.gov/pubmed/23898270 http://dx.doi.org/10.1159/000351834 |